Cerevel Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile


Boston, MA USA
Total Funding:N/A
Lead Investor(s):N/A

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Cerevel Therapeutics's estimated annual revenue is currently $22.9M per year.(?)
  • Cerevel Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • Cerevel Therapeutics has 114 Employees.(?)
  • Cerevel Therapeutics grew their employee count by 16% last year.
  • Cerevel Therapeutics currently has 1 job openings.

Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinsonᅢᄁ¬ツᆲ¬トᄁs, Alzheimerᅢᄁ¬ツᆲ¬トᄁs, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.